Predicting Dysglycemia in Individuals With Gestational Diabetes Immediately Postpartum Using Continuous Glucose Monitoring

Participation Requirements

• Sex:

  FEMALE

• Eligible Ages:

  18 and up

Participation Criteria

Inclusion Criteria:

* Pregnant individuals age 18 and older
* Diagnosed with gestational diabetes by the Diabetes Canada guidelines (including both the preferred or alternate testing approaches) or have an HbA1c of 6.0-6.4% during pregnancy
* Have any of the following: have an elevated fasting glucose (≥ 5.3 mmol/L) on the diagnostic 75g OGTT in pregnancy; required insulin or metformin for treatment during pregnancy; body mass index (BMI) ≥ 25kg/m2, yes/no (\<27 weeks gestation BMI of ≥25 kg/m2 or ≥27 weeks gestation predicted BMI of ≥ 25 kg/m2 using (current weight in kg - 10kg)/height in meters2)
* Planned in-hospital delivery
* Able to provide informed consent
* Willingness to use the study device and complete assessments
* Have access to email in order to complete participant questionnaire through REDCap

Exclusion Criteria:

* Non-gestational diabetes (i.e. pre-existing diabetes)
* Planned x-ray, MRI or CT within 3 weeks postpartum
* Has an implantable medical device (ex. pacemaker)
* On medications known to affect glucose metabolism (for example glucocorticoids, metformin etc.)
* On medications which may interfere with the Freestyle Libre 2 accuracy (for example Vitamin C \>1000mg/day)
* Unable to speak and understand French or English
* Unable to consent or declined informed consent